Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Oct 1;102(7):1301–1310. doi: 10.1172/JCI3338

Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

T F Choudhri 1, B L Hoh 1, H G Zerwes 1, C J Prestigiacomo 1, S C Kim 1, E S Connolly Jr 1, G Kottirsch 1, D J Pinsky 1
PMCID: PMC508977  PMID: 9769322

Abstract

Treatment options in acute stroke are limited by a dearth of safe and effective regimens for recanalization of an occluded cerebrovascular tributary, as well as by the fact that patients present only after the occlusive event is established. We hypothesized that even if the site of major arterial occlusion is recanalized after stroke, microvascular thrombosis continues to occur at distal sites, reducing postischemic flow and contributing to ongoing neuronal death. To test this hypothesis, and to show that microvascular thrombosis occurs as an ongoing, dynamic process after the onset of stroke, we tested the effects of a potent antiplatelet agent given both before and after the onset of middle cerebral arterial (MCA) occlusion in a murine model of stroke. After 45 min of MCA occlusion and 23 h of reperfusion, fibrin accumulates in the ipsilateral cerebral hemisphere, based upon immunoblotting, and localizes to microvascular lumena, based upon immunostaining. In concordance with these data, there is a nearly threefold increase in the ipsilateral accumulation of 111In-labeled platelets in mice subjected to stroke compared with mice not subjected to stroke. When a novel inhibitor of the glycoprotein IIb/IIIa receptor (SDZ GPI 562) was administered immediately before MCA occlusion, platelet accumulation was reduced 48%, and fibrin accumulation was reduced by 47% by immunoblot densitometry. GPI 562 exhibited a dose-dependent reduction of cerebral infarct volumes measured by triphenyltetrazolium chloride staining, as well as improvement in postischemic cerebral blood flow, measured by laser doppler. GPI 562 caused a dose-dependent increase in tail vein bleeding time, but intracerebral hemorrhage (ICH) was not significantly increased at therapeutic doses; however, there was an increase in ICH at the highest doses tested. When given immediately after withdrawal of the MCA occluding suture, GPI 562 was shown to reduce cerebral infarct volumes by 70%. These data support the hypothesis that in ischemic regions of brain, microvascular thrombi continue to accumulate even after recanalization of the MCA, contributing to postischemic hypoperfusion and ongoing neuronal damage.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bederson J. B., Pitts L. H., Tsuji M., Nishimura M. C., Davis R. L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986 May-Jun;17(3):472–476. doi: 10.1161/01.str.17.3.472. [DOI] [PubMed] [Google Scholar]
  2. Bowie E. J., Owen C. A., Jr The bleeding time. Prog Hemost Thromb. 1974;2(0):249–271. [PubMed] [Google Scholar]
  3. Bronner L. L., Kanter D. S., Manson J. E. Primary prevention of stroke. N Engl J Med. 1995 Nov 23;333(21):1392–1400. doi: 10.1056/NEJM199511233332106. [DOI] [PubMed] [Google Scholar]
  4. Choudhri T. F., Hoh B. L., Solomon R. A., Connolly E. S., Jr, Pinsky D. J. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke. 1997 Nov;28(11):2296–2302. doi: 10.1161/01.str.28.11.2296. [DOI] [PubMed] [Google Scholar]
  5. Coller B. S., Anderson K., Weisman H. F. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb Haemost. 1995 Jul;74(1):302–308. [PubMed] [Google Scholar]
  6. Coller B. S., Folts J. D., Smith S. R., Scudder L. E., Jordan R. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation. 1989 Dec;80(6):1766–1774. doi: 10.1161/01.cir.80.6.1766. [DOI] [PubMed] [Google Scholar]
  7. Connolly E. S., Jr, Winfree C. J., Prestigiacomo C. J., Kim S. C., Choudhri T. F., Hoh B. L., Naka Y., Solomon R. A., Pinsky D. J. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res. 1997 Sep;81(3):304–310. doi: 10.1161/01.res.81.3.304. [DOI] [PubMed] [Google Scholar]
  8. Connolly E. S., Jr, Winfree C. J., Springer T. A., Naka Y., Liao H., Yan S. D., Stern D. M., Solomon R. A., Gutierrez-Ramos J. C., Pinsky D. J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest. 1996 Jan 1;97(1):209–216. doi: 10.1172/JCI118392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Connolly E. S., Jr, Winfree C. J., Stern D. M., Solomon R. A., Pinsky D. J. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery. 1996 Mar;38(3):523–532. doi: 10.1097/00006123-199603000-00021. [DOI] [PubMed] [Google Scholar]
  10. Cook N. S., Zerwes H. G., Tapparelli C., Powling M., Singh J., Metternich R., Hagenbach A. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost. 1993 Sep 1;70(3):531–539. [PubMed] [Google Scholar]
  11. Cortelazzo S., Finazzi G., Ruggeri M., Vestri O., Galli M., Rodeghiero F., Barbui T. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995 Apr 27;332(17):1132–1136. doi: 10.1056/NEJM199504273321704. [DOI] [PubMed] [Google Scholar]
  12. Del Zoppo G. J., Copeland B. R., Harker L. A., Waltz T. A., Zyroff J., Hanson S. R., Battenberg E. Experimental acute thrombotic stroke in baboons. Stroke. 1986 Nov-Dec;17(6):1254–1265. doi: 10.1161/01.str.17.6.1254. [DOI] [PubMed] [Google Scholar]
  13. Dietrich W. D., Dewanjee S., Prado R., Watson B. D., Dewanjee M. K. Transient platelet accumulation in the rat brain after common carotid artery thrombosis. An 111In-labeled platelet study. Stroke. 1993 Oct;24(10):1534–1540. doi: 10.1161/01.str.24.10.1534. [DOI] [PubMed] [Google Scholar]
  14. Emeis J. J., Lindeman J., Nieuwenhuizen W. Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol. 1981 Jun;103(3):337–344. [PMC free article] [PubMed] [Google Scholar]
  15. Fisher M., Levine P. H., Fullerton A. L., Forsberg A., Duffy C. P., Hoogasian J. J., Drachman D. A. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol. 1982 Nov;39(11):692–695. doi: 10.1001/archneur.1982.00510230018006. [DOI] [PubMed] [Google Scholar]
  16. Gryglewski R. J., Nowak S., Kostka-Trabka E., Kusmiderski J., Dembinska-Kiec A., Bieron K., Basista M., Blaszczyk B. Treatment of ischaemic stroke with prostacyclin. Stroke. 1983 Mar-Apr;14(2):197–202. doi: 10.1161/01.str.14.2.197. [DOI] [PubMed] [Google Scholar]
  17. Hawiger J. Mechanisms involved in platelet vessel wall interaction. Thromb Haemost. 1995 Jul;74(1):369–372. [PubMed] [Google Scholar]
  18. Heye N., Paetzold C., Steinberg R., Cervos-Navarro J. The topography of microthrombi in ischemic brain infarct. Acta Neurol Scand. 1992 Nov;86(5):450–454. doi: 10.1111/j.1600-0404.1992.tb05122.x. [DOI] [PubMed] [Google Scholar]
  19. Iwamoto T., Kubo H., Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke. 1995 Jan;26(1):52–56. doi: 10.1161/01.str.26.1.52. [DOI] [PubMed] [Google Scholar]
  20. Jafar J. J., Menoni R., Feinberg H., LeBreton G., Crowell R. M. Selective platelet deposition during focal cerebral ischemia in cats. Stroke. 1989 May;20(5):664–667. doi: 10.1161/01.str.20.5.664. [DOI] [PubMed] [Google Scholar]
  21. Kochanek P. M., Dutka A. J., Kumaroo K. K., Hallenbeck J. M. Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. Stroke. 1988 Jun;19(6):693–699. doi: 10.1161/01.str.19.6.693. [DOI] [PubMed] [Google Scholar]
  22. Kotzé H. F., Badenhorst P. N., Lamprecht S., Meiring M., Van Wyk V., Nuyts K., Stassen J. M., Vermylen J., Deckmyn H. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model. Thromb Haemost. 1995 Aug;74(2):751–757. [PubMed] [Google Scholar]
  23. Lahiri B., Koehn J. A., Canfield R. E., Birken S., Lewis J. Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin. Thromb Res. 1981 Jul 1;23(1-2):103–112. doi: 10.1016/0049-3848(81)90243-7. [DOI] [PubMed] [Google Scholar]
  24. Lawson C. A., Yan S. D., Yan S. F., Liao H., Zhou Y. S., Sobel J., Kisiel W., Stern D. M., Pinsky D. J. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest. 1997 Apr 1;99(7):1729–1738. doi: 10.1172/JCI119337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lind S. E. The bleeding time does not predict surgical bleeding. Blood. 1991 Jun 15;77(12):2547–2552. [PubMed] [Google Scholar]
  26. Mizutani H., Furubayashi T., Kuriu A., Take H., Tomiyama Y., Yoshida H., Nakamura Y., Inaba M., Kurata Y., Yonezawa T. Analyses of thrombocytopenia in idiopathic thrombocytopenic purpura-prone mice by platelet transfer experiments between (NZW x BXSB)F1 and normal mice. Blood. 1990 May 1;75(9):1809–1812. [PubMed] [Google Scholar]
  27. Naka Y., Chowdhury N. C., Liao H., Roy D. K., Oz M. C., Michler R. E., Pinsky D. J. Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res. 1995 May;76(5):900–906. doi: 10.1161/01.res.76.5.900. [DOI] [PubMed] [Google Scholar]
  28. Obrenovitch T. P., Hallenbeck J. M. Platelet accumulation in regions of low blood flow during the postischemic period. Stroke. 1985 Mar-Apr;16(2):224–234. doi: 10.1161/01.str.16.2.224. [DOI] [PubMed] [Google Scholar]
  29. Ogawa S., Gerlach H., Esposito C., Pasagian-Macaulay A., Brett J., Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest. 1990 Apr;85(4):1090–1098. doi: 10.1172/JCI114540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Okada Y., Copeland B. R., Fitridge R., Koziol J. A., del Zoppo G. J. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke. 1994 Sep;25(9):1847–1854. doi: 10.1161/01.str.25.9.1847. [DOI] [PubMed] [Google Scholar]
  31. Parker R. I., Gralnick H. R. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor. Blood. 1986 Sep;68(3):732–736. [PubMed] [Google Scholar]
  32. Pinsky D. J., Oz M. C., Koga S., Taha Z., Broekman M. J., Marcus A. J., Liao H., Naka Y., Brett J., Cannon P. J. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest. 1994 May;93(5):2291–2297. doi: 10.1172/JCI117230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Valles J., Santos M. T., Marcus A. J., Safier L. B., Broekman M. J., Islam N., Ullman H. L., Aznar J. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest. 1993 Sep;92(3):1357–1365. doi: 10.1172/JCI116709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weiss H. J., Hawiger J., Ruggeri Z. M., Turitto V. T., Thiagarajan P., Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest. 1989 Jan;83(1):288–297. doi: 10.1172/JCI113871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Willerson J. T. Inhibitors of platelet glycoprotein IIb/IIIa receptors. Will they be useful when given chronically? Circulation. 1996 Sep 1;94(5):866–868. doi: 10.1161/01.cir.94.5.866. [DOI] [PubMed] [Google Scholar]
  36. Willette R. N., Sauermelch C. F., Rycyna R., Sarkar S., Feuerstein G. Z., Nichols A. J., Ohlstein E. H. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis. Stroke. 1992 May;23(5):703–711. doi: 10.1161/01.str.23.5.703. [DOI] [PubMed] [Google Scholar]
  37. Williams M. J., Du X., Loftus J. C., Ginsberg M. H. Platelet adhesion receptors. Semin Cell Biol. 1995 Oct;6(5):305–314. doi: 10.1006/scel.1995.0040. [DOI] [PubMed] [Google Scholar]
  38. Winfree C. J., Baker C. J., Connolly E. S., Jr, Fiore A. J., Solomon R. A. Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model. Neurosurgery. 1996 Jun;38(6):1216–1222. doi: 10.1097/00006123-199606000-00034. [DOI] [PubMed] [Google Scholar]
  39. Zhang Z., Chopp M., Zhang R. L., Goussev A. A mouse model of embolic focal cerebral ischemia. J Cereb Blood Flow Metab. 1997 Oct;17(10):1081–1088. doi: 10.1097/00004647-199710000-00010. [DOI] [PubMed] [Google Scholar]
  40. del Zoppo G. J. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev. 1994 Spring;6(1):47–96. [PubMed] [Google Scholar]
  41. van Kooten F., Ciabattoni G., Patrono C., Schmitz P. I., van Gijn J., Koudstaal P. J. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 1994 Feb;25(2):278–281. doi: 10.1161/01.str.25.2.278. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES